Boston Properties (BXP) has shown significant
trading activity, with notable
shares purchases by Natixis Advisors L.P., International Assets Investment Management LLC, and New York Life Investment Management LLC among others. BXP also has significant holdings with Amalgamated Bank and Russell Investments Group. The
leasing performance of BXP remains strong. As a real estate investment trust, it outperformed Q4 FFO (Funds from Operations) and revenue estimates. However, predictions for 2024 present a lowered view. The company is actively increasing its
stake in office portfolios and has launched a $600M ATM Offering Program. Boston Properties has been involved in
life-science assets, selling a 45% stake while undergoing construction projects like Cambridge’s tallest building. There are expectations of resilience in BXP's Q1 2024 results and a trimmed profit forecast due to rising rates. Multiple earnings calls were noted, and there are speculations on key factors impacting BXP's future earnings. The construction in Kendall Square has led to a lawsuit with Thermo Fisher's Brammer Bio. Lastly, Boston Properties announced a joint venture with the Canada Pension Plan Investment Board to develop Class A Office, indicating a further commitment to its portfolio.
Boston Properties BXP News Analytics from Wed, 02 Aug 2023 07:00:00 GMT to Mon, 13 May 2024 13:15:41 GMT -
Rating 4
- Innovation 3
- Information 7
- Rumor -4
